Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Merrill Lynch HCC;positive+good for newbies to listen to. Most investors who have been here awhile have heard most of what was said at today's Bank of America Merrill Lynch 2018 Health Care Conference. Essentially, all systems go on pozi and Rolontis.

For the 1st time they presented data on all HER2 exon 20 solid tumors which is present in 28 different tumor types. Percentage wise, some tumor types are found in a much greater percentage than seen in NSCLC. Since we got the cheat sheet from Dr Haymach's video previously that these other cancer types will double the # of patients compared to that found in NSCLC, thankfully, we don't need to research how many patients those percentages encompass. Also interesting about that slide is that it's only for HER2, they didn't show EGFR.

Overall, just an ALL SYSTEMS GO type of CC. Refreshing!